Bone Medical completes merger with Revenir
By Melissa Trudinger
Monday, 23 August, 2004
Monday, 23 August, 2004
UK biotech company Bone Limited has completed its merger with Perth-based listed property management company Revenir (ASX: REV) after a successful capital raising of $2.5 million closed oversubscribed earlier in the month.
The company, which will be known as Bone Medical, is expected to start trading on August 31, 2004 under the stock symbol BNE.
Related News
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
